Literature DB >> 26014222

Molecular pathways in protecting the liver from ischaemia/reperfusion injury: a 2015 update.

Jordi Gracia-Sancho1, Araní Casillas-Ramírez2, Carmen Peralta2.   

Abstract

Ischaemia/reperfusion injury is an important cause of liver damage during surgical procedures such as hepatic resection and liver transplantation, and represents the main cause of graft dysfunction post-transplantation. Molecular processes occurring during hepatic ischaemia/reperfusion are diverse, and continuously include new and complex mechanisms. The present review aims to summarize the newest concepts and hypotheses regarding the pathophysiology of liver ischaemia/reperfusion, making clear distinction between situations of cold and warm ischaemia. Moreover, the most updated therapeutic strategies including pharmacological, genetic and surgical interventions, as well as some of the scientific controversies in the field are described.

Entities:  

Mesh:

Year:  2015        PMID: 26014222     DOI: 10.1042/CS20150223

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  32 in total

1.  Interpatient heterogeneity in hepatic microvascular blood flow during vascular inflow occlusion (Pringle manoeuvre).

Authors:  Eric Felli; Edoardo Maria Muttillo; Emanuele Felli
Journal:  Hepatobiliary Surg Nutr       Date:  2021-06       Impact factor: 7.293

2.  Tubular mitochondrial AKT1 is activated during ischemia reperfusion injury and has a critical role in predisposition to chronic kidney disease.

Authors:  Hugo Y-H Lin; Yumay Chen; Yu-Han Chen; Albert P Ta; Hsiao-Chen Lee; Grant R MacGregor; Nosratola D Vaziri; Ping H Wang
Journal:  Kidney Int       Date:  2020-12-13       Impact factor: 10.612

3.  Donor Diabetes and Prolonged Cold Ischemia Time Synergistically Increase the Risk of Graft Failure After Liver Transplantation.

Authors:  Isabel M A Brüggenwirth; Natasha H Dolgin; Robert J Porte; Adel Bozorgzadeh; Paulo N A Martins
Journal:  Transplant Direct       Date:  2017-06-12

4.  Down-regulation of nuclear HMGB1 reduces ischemia-induced HMGB1 translocation and release and protects against liver ischemia-reperfusion injury.

Authors:  Guangyuan Zhao; Cheng Fu; Lu Wang; Lan Zhu; Yutao Yan; Ying Xiang; Fang Zheng; Feili Gong; Song Chen; Gang Chen
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

Review 5.  The Role of Normothermic Perfusion in Liver Transplantation (TRaNsIT Study): A Systematic Review of Preliminary Studies.

Authors:  Kumar Jayant; Isabella Reccia; Francesco Virdis; A M James Shapiro
Journal:  HPB Surg       Date:  2018-05-17

Review 6.  Novel Targets for Treating Ischemia-Reperfusion Injury in the Liver.

Authors:  Weili Yang; Ji Chen; Yuhong Meng; Zhenzhen Chen; Jichun Yang
Journal:  Int J Mol Sci       Date:  2018-04-26       Impact factor: 5.923

7.  The liver protection of propylene glycol alginate sodium sulfate preconditioning against ischemia reperfusion injury: focusing MAPK pathway activity.

Authors:  Shizan Xu; Peiqin Niu; Kan Chen; Yujing Xia; Qiang Yu; Ning Liu; Jingjing Li; Sainan Li; Liwei Wu; Jiao Feng; Wenwen Wang; Xiya Lu; Tong Liu; Fan Wang; Weiqi Dai; Xiaoming Fan; Wenhui Mo; Ling Xu; Chuanyong Guo
Journal:  Sci Rep       Date:  2017-11-09       Impact factor: 4.379

8.  Multiparametric functional magnetic resonance imaging for evaluation of hepatic warm ischemia-reperfusion injury in a rabbit model.

Authors:  Qian Ji; Zhi Qiang Chu; Tao Ren; Shi Chao Xu; Long Jiang Zhang; Wen Shen; Guang Ming Lu
Journal:  BMC Gastroenterol       Date:  2017-12-15       Impact factor: 3.067

Review 9.  Effect of Hepatic Macrophage Polarization and Apoptosis on Liver Ischemia and Reperfusion Injury During Liver Transplantation.

Authors:  Liping Ye; Saiqin He; Xinli Mao; Yu Zhang; Yue Cai; Shaowei Li
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 7.561

Review 10.  The Role of Adipokines in Surgical Procedures Requiring Both Liver Regeneration and Vascular Occlusion.

Authors:  Ana Isabel Álvarez-Mercado; Esther Bujaldon; Jordi Gracia-Sancho; Carmen Peralta
Journal:  Int J Mol Sci       Date:  2018-10-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.